{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:46:56Z","timestamp":1792813616695,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["399632"],"award-info":[{"award-number":["399632"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the world. There is strong evidence that dyslipidemia and other cardio-metabolic disorders are highly prevalent in patients with NAFLD. This trial aimed at examining the effect of sesame oil (SO) in the context of a weight loss program on lipid profile, blood pressure, and anthropometric indices in women with NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This randomized, double-blind, controlled trial was carried out on 60 women with NAFLD. Subjects were randomly assigned to the SO group (<jats:italic>n<\/jats:italic>\u2009=\u200930) and sunflower oil (SFO) group (<jats:italic>n<\/jats:italic>\u2009=\u200930), each person consuming 30\u00a0g of oil per day for 12\u00a0weeks. All the participants received a hypocaloric diet (\u2212\u2009500\u00a0kcal\/day) during the study. Lipid profile, blood pressure, and anthropometric indices were assessed at pre- and post-intervention phases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 53 participants completed the study. Following 12\u00a0weeks of intervention, anthropometric indices (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and systolic blood pressure (SBP) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) were significantly decreased in both groups and diastolic blood pressure (DBP) was significantly decreased in So group (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). There was no significant change in lipid profile\u00a0in both groups (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). After adjusting for confounders, DBP (<jats:italic>p<\/jats:italic>\u2009=\u20090.031) and total cholesterol (TC) divided by high-density lipoprotein cholesterol (HDL-C) (<jats:italic>p<\/jats:italic>\u2009=\u20090.039) in the SO group were significantly reduced compared to the SFO group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present clinical trial revealed that SO and SFO may not differently affect anthropometric indices, SBP, and lipid profile except for TC\/HDL-C. In addition, SO may be effective in improvement of DBP and TC\/HDL-C compared to the SFO group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Ethical approval of this trial was obtained at Isfahan University of Medical Sciences with the reference number of IR.MUI.RESEARCH.REC.1399.548\u00a0(<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ethics.research.ac.ir\/ProposalCertificateEn.php?id=158942&amp;Print=true&amp;NoPrintHeader=true&amp;NoPrintFooter=true&amp;NoPrintPageBorder=true&amp;LetterPrint=true\">https:\/\/ethics.research.ac.ir\/ProposalCertificateEn.php?id=158942&amp;Print=true&amp;NoPrintHeader=true&amp;NoPrintFooter=true&amp;NoPrintPageBorder=true&amp;LetterPrint=true<\/jats:ext-link>), and it was registered before the start of the patient recruitment on December 12<jats:sup>th<\/jats:sup>, 2020 in the Iranian Registry of Clinical Trials (IRCT) with the registration number of <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.irct.ir\/trial\/52288\">IRCT20140208016529N6<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06451-1","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:06Z","timestamp":1657278186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The effect of sesame oil consumption compared to sunflower oil on lipid profile, blood pressure, and anthropometric indices in women with non-alcoholic fatty liver disease: a randomized double-blind controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-3457","authenticated-orcid":false,"given":"Hamid","family":"Vahedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-166X","authenticated-orcid":false,"given":"Masoumeh","family":"Atefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-4124","authenticated-orcid":false,"given":"Mohammad Hassan","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4555-0992","authenticated-orcid":false,"given":"Akbar","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"6451_CR1","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","volume":"24","author":"C Anania","year":"2018","unstructured":"Anania C, Massimo Perla F, Olivero F, Pacifico L, Chiesa C. Mediterranean diet and nonalcoholic fatty liver disease. World J Gastroenterol. 2018;24:2083\u201394. https:\/\/doi.org\/10.3748\/wjg.v24.i19.2083.","journal-title":"World J Gastroenterol"},{"key":"6451_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72:1605\u201316. https:\/\/doi.org\/10.1002\/hep.31173.","journal-title":"Hepatology"},{"key":"6451_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/TP.0000000000002484","volume":"103","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Marchesini G, Pinto-Cortez H, Petta S. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 2019;103:22\u20137. https:\/\/doi.org\/10.1097\/TP.0000000000002484.","journal-title":"Transplantation"},{"key":"6451_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"T Huang","year":"2020","unstructured":"Huang T, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50:1038\u201347. https:\/\/doi.org\/10.1111\/imj.14709.","journal-title":"Intern Med J"},{"key":"6451_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/apt.15163","volume":"49","author":"S Sookoian","year":"2019","unstructured":"Sookoian S, Pirola CJ. Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome \u2013 translating knowledge from systems biology to the bedside. Aliment Pharmacol Ther. 2019;49:516\u201327. https:\/\/doi.org\/10.1111\/apt.15163.","journal-title":"Aliment Pharmacol Ther"},{"key":"6451_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32228","author":"JM Paik","year":"2021","unstructured":"Paik JM, Kabbara K, Eberly KE, Younossi Y, Henry L, Younossi ZM. Global burden of NAFLD and chronic liver disease among adolescents and young adults. Hepatology. 2021. https:\/\/doi.org\/10.1002\/hep.32228.","journal-title":"Hepatology"},{"key":"6451_CR7","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3390\/ijms20092215","volume":"20","author":"H El Hadi","year":"2019","unstructured":"El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Cardio-metabolic disorders in non-alcoholic fatty liver disease. Int J Mol Sci. 2019;20:2215. https:\/\/doi.org\/10.3390\/ijms20092215.","journal-title":"Int J Mol Sci"},{"key":"6451_CR8","doi-asserted-by":"publisher","unstructured":"Golabi P, Otgonsuren M, De Avila L, Sayiner M, Rafiq N, Younossi ZM. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD). Med (United States). 2018;97. https:\/\/doi.org\/10.1097\/MD.0000000000010214.","DOI":"10.1097\/MD.0000000000010214"},{"key":"6451_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","volume":"41","author":"N Motamed","year":"2017","unstructured":"Motamed N, Rabiee B, Poustchi H, Dehestani B, Hemasi GR, Khonsari MR, et al. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clin Res Hepatol Gastroenterol. 2017;41:31\u20138. https:\/\/doi.org\/10.1016\/j.clinre.2016.07.005.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"6451_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/advances\/nmx007","volume":"9","author":"ES George","year":"2018","unstructured":"George ES, Forsyth A, Itsiopoulos C, Nicoll AJ, Ryan M, Sood S, et al. Practical dietary recommendations for the prevention andmanagement of nonalcoholic fatty liver disease in adults. Adv Nutr. 2018;9:30\u201340. https:\/\/doi.org\/10.1093\/advances\/nmx007.","journal-title":"Adv Nutr"},{"key":"6451_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jnutbio.2013.10.013","volume":"25","author":"S Periasamy","year":"2014","unstructured":"Periasamy S, Chien SP, Chang PC, Hsu DZ, Liu MY. Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis. J Nutr Biochem. 2014;25:232\u201340. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.10.013.","journal-title":"J Nutr Biochem"},{"key":"6451_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.23751\/pn.v20i1-S.5854","volume":"20","author":"M Atefi","year":"2018","unstructured":"Atefi M, Pishdad GR, Faghih S. Canola oil and olive oil impact on lipid profile and blood pressure in women with type 2 diabetes: a randomized, controlled trial. Prog Nutr. 2018;20:102\u20139. https:\/\/doi.org\/10.23751\/pn.v20i1-S.5854.","journal-title":"Prog Nutr."},{"key":"6451_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343\u201351. https:\/\/doi.org\/10.1172\/JCI23621.","journal-title":"J Clin Invest"},{"key":"6451_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jff.2017.08.036","volume":"37","author":"M Kim","year":"2017","unstructured":"Kim M, Woo M, Noh JS, Choe E, Song YO. Sesame oil lignans inhibit hepatic endoplasmic reticulum stress and apoptosis in high-fat diet-fed mice. J Funct Foods. 2017;37:658\u201365. https:\/\/doi.org\/10.1016\/j.jff.2017.08.036.","journal-title":"J Funct Foods"},{"key":"6451_CR15","doi-asserted-by":"publisher","first-page":"1477S","DOI":"10.1093\/ajcn\/83.6.1477s","volume":"83","author":"JL Breslow","year":"2006","unstructured":"Breslow JL. n-3 Fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83:1477S-1482S. https:\/\/doi.org\/10.1093\/ajcn\/83.6.1477s.","journal-title":"Am J Clin Nutr"},{"key":"6451_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3181\/0711-MR-311","volume":"233","author":"AP Simopoulos","year":"2008","unstructured":"Simopoulos AP. The importance of the omega-6\/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233:674\u201388. https:\/\/doi.org\/10.3181\/0711-MR-311.","journal-title":"Exp Biol Med"},{"key":"6451_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.22122\/arya.v15i4.1940","volume":"15","author":"M Amiri","year":"2019","unstructured":"Amiri M, Ghaneian MT, Zare-Sakhvidi MJ, Rahmanian M, Nadjarzadeh A, Moghtaderi F, et al. The effect of canola oil compared with sesame and sesame-canola oil on cardiometabolic biomarkers in patients with type 2 diabetes: design and research protocol of a randomized, triple-blind, three-way, crossover clinical trial. ARYA Atheroscler. 2019;15:168\u201378. https:\/\/doi.org\/10.22122\/arya.v15i4.1940.","journal-title":"ARYA Atheroscler."},{"key":"6451_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/07315724.2018.1500183","volume":"38","author":"F Aslam","year":"2019","unstructured":"Aslam F, Iqbal S, Nasir M, Anjum AA. White sesame seed oil mitigates blood glucose level, reduces oxidative stress, and improves biomarkers of hepatic and renal function in participants with type 2 diabetes mellitus. J Am Coll Nutr. 2019;38:235\u201346. https:\/\/doi.org\/10.1080\/07315724.2018.1500183.","journal-title":"J Am Coll Nutr"},{"key":"6451_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/dia.2013.0178","volume":"16","author":"P Nigam","year":"2014","unstructured":"Nigam P, Bhatt S, Misra A, Chadha DS, Vaidya M, Dasgupta J, et al. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male asian indians with nonalcoholic fatty liver disease. Diabetes Technol Ther. 2014;16:255\u201361. https:\/\/doi.org\/10.1089\/dia.2013.0178.","journal-title":"Diabetes Technol Ther"},{"key":"6451_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41430-019-0438-5","volume":"73","author":"A Farajbakhsh","year":"2019","unstructured":"Farajbakhsh A, Mazloomi SM, Mazidi M, Rezaie P, Akbarzadeh M, Ahmad SP, et al. Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial. Eur J Clin Nutr. 2019;73:1403\u201311. https:\/\/doi.org\/10.1038\/s41430-019-0438-5.","journal-title":"Eur J Clin Nutr"},{"key":"6451_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/jmf.2006.9.487","volume":"9","author":"S Bhaskaran","year":"2006","unstructured":"Bhaskaran S, Santanam N, Penumetcha M, Parthasarathy S. Inhibition of atherosclerosis in low-density lipoprotein receptor-negative mice by sesame oil. J Med Food. 2006;9:487\u201390. https:\/\/doi.org\/10.1089\/jmf.2006.9.487.","journal-title":"J Med Food"},{"key":"6451_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1089\/jmf.2006.9.408","volume":"9","author":"D Sankar","year":"2006","unstructured":"Sankar D, Ramakrishna Rao M, Sambandam G, Pugalendi KV. A pilot study of open label sesame oil in hypertensive diabetics. J Med Food. 2006;9:408\u201312. https:\/\/doi.org\/10.1089\/jmf.2006.9.408.","journal-title":"J Med Food"},{"key":"6451_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cccn.2004.12.009","volume":"355","author":"D Sankar","year":"2005","unstructured":"Sankar D, Sambandam G, Ramakrishna Rao M, Pugalendi KV. Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils. Clin Chim Acta. 2005;355:97\u2013104. https:\/\/doi.org\/10.1016\/j.cccn.2004.12.009.","journal-title":"Clin Chim Acta"},{"key":"6451_CR24","doi-asserted-by":"publisher","unstructured":"Abdul-Lattif RF. Effect of sesame oil on lipid profile and liver enzymes in male albino rats treated with carbone tetrachloride (CCl4). Ibn AL- Haitham J Pure Appl Sci. 2018;41. https:\/\/doi.org\/10.30526\/2017.ihsciconf.1769.","DOI":"10.30526\/2017.ihsciconf.1769"},{"key":"6451_CR25","first-page":"1059","volume":"4","author":"SM Namayandeh","year":"2013","unstructured":"Namayandeh SM, Kaseb F, Lesan S. Olive and sesame oil effect on lipid profile in hypercholesterolemic patients, which better? Int J Prev Med. 2013;4:1059\u201362.","journal-title":"Int J Prev Med"},{"key":"6451_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.clnu.2010.11.005","volume":"30","author":"D Sankar","year":"2011","unstructured":"Sankar D, Ali A, Sambandam G, Rao R. Sesame oil exhibits synergistic effect with anti-diabetic medication in patients with type 2 diabetes mellitus. Clin Nutr. 2011;30:351\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2010.11.005.","journal-title":"Clin Nutr"},{"key":"6451_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09709274.2007.11906001","volume":"22","author":"A Mitra","year":"2007","unstructured":"Mitra A. Study on the benefits of sesame oil over coconut oil in patients of insulin resistance syndrome, notably type 2 diabetes and dyslipidaemia. J Hum Ecol. 2007;22:61\u20136. https:\/\/doi.org\/10.1080\/09709274.2007.11906001.","journal-title":"J Hum Ecol"},{"key":"6451_CR28","first-page":"19","volume":"79","author":"D Sankar","year":"2006","unstructured":"Sankar D, Ramakrishna Rao M, Sambandam G, Pugalendi KV. Effect of sesame oil on diuretics or \u00df-blockers in the modulation of blood pressure, anthropometry, lipid profile, and redox status. Yale J Biol Med. 2006;79:19\u201326.","journal-title":"Yale J Biol Med"},{"key":"6451_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1053\/jren.2000.16326","volume":"10","author":"P Khajehdehi","year":"2000","unstructured":"Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr. 2000;10:191\u20135. https:\/\/doi.org\/10.1053\/jren.2000.16326.","journal-title":"J Ren Nutr"},{"key":"6451_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jnutbio.2013.11.008","volume":"25","author":"S Periasamy","year":"2014","unstructured":"Periasamy S, Hsu DZ, Chang PC, Liu MY. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-\u03b3. J Nutr Biochem. 2014;25:337\u201344. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.11.008.","journal-title":"J Nutr Biochem"},{"key":"6451_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1177\/0394632015575950","volume":"28","author":"MM Soliman","year":"2015","unstructured":"Soliman MM, Attia HF, El-Ella GAA. Genetic and histopathological alterations induced by cypermethrin in rat kidney and liver: Protection by sesame oil. Int J Immunopathol Pharmacol. 2015;28:508\u201320. https:\/\/doi.org\/10.1177\/0394632015575950.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"6451_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/03601234.2012.640913","volume":"47","author":"HM Abdou","year":"2012","unstructured":"Abdou HM, Hussien HM, Yousef MI. Deleterious effects of cypermethrin on rat liver and kidney: Protective role of sesame oil. J Environ Sci Heal - Part B Pestic Food Contam Agric Wastes. 2012;47:306\u201314. https:\/\/doi.org\/10.1080\/03601234.2012.640913.","journal-title":"J Environ Sci Heal - Part B Pestic Food Contam Agric Wastes"},{"key":"6451_CR33","first-page":"1895","volume":"45","author":"AW Chan","year":"2017","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: Defining standard protocol items for clinical trials. Japanese Pharmacol Ther. 2017;45:1895\u2013904.","journal-title":"Japanese Pharmacol Ther"},{"key":"6451_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3399","volume":"37","author":"H Raeisi-Dehkordi","year":"2021","unstructured":"Raeisi-Dehkordi H, Amiri M, Zimorovat A, Moghtaderi F, Zarei S, Forbes SC, et al. Canola oil compared with sesame and sesame-canola oil on glycaemic control and liver function in patients with type 2 diabetes: a three-way randomized triple-blind cross-over trial. Diabetes Metab Res Rev. 2021;37: e3399. https:\/\/doi.org\/10.1002\/dmrr.3399.","journal-title":"Diabetes Metab Res Rev"},{"key":"6451_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","volume":"51","author":"MD Mifflin","year":"1990","unstructured":"Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241\u20137. https:\/\/doi.org\/10.1093\/ajcn\/51.2.241.","journal-title":"Am J Clin Nutr"},{"key":"6451_CR36","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498-504. https:\/\/doi.org\/10.1097\/00005768-200009001-00009.","journal-title":"Med Sci Sports Exerc"},{"key":"6451_CR37","doi-asserted-by":"crossref","unstructured":"Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. New York:  Chapman and Hall\/CRC; 2017.","DOI":"10.1201\/9781315183084"},{"key":"6451_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nut.2018.02.021","volume":"57","author":"S Rezaei","year":"2019","unstructured":"Rezaei S, Akhlaghi M, Sasani MR, Barati BR. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial. Nutrition. 2019;57:154\u201361. https:\/\/doi.org\/10.1016\/j.nut.2018.02.021.","journal-title":"Nutrition"},{"key":"6451_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1017\/S0007114515005012","volume":"115","author":"S Khalesi","year":"2016","unstructured":"Khalesi S, Paukste E, Nikbakht E, Khosravi-Boroujeni H. Sesame fractions and lipid profiles: a systematic review and meta-analysis of controlled trials. Br J Nutr. 2016;115:764\u201373. https:\/\/doi.org\/10.1017\/S0007114515005012.","journal-title":"Br J Nutr"},{"key":"6451_CR40","doi-asserted-by":"publisher","unstructured":"Huang H, Zhou G, Pu R, Cui Y, Liao D. Clinical evidence of dietary supplementation with sesame on cardiovascular risk factors: An updated meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021;1\u201311. https:\/\/doi.org\/10.1080\/10408398.2021.1888689.","DOI":"10.1080\/10408398.2021.1888689"},{"key":"6451_CR41","doi-asserted-by":"publisher","unstructured":"Mekky RH, Hegazy MM, C\u00e1diz-Gurrea M de la L, Fern\u00e1ndez-Ochoa \u00c1, Segura Carretero A. Bioactive phytochemicals from Sesame oil processing by-products. In: Ramadan Hassanien MF, editor. Bioact Phytochem from Veg Oil Oilseed Process By-products. Cham: Springer International Publishing; 2021. p. 1\u201340. https:\/\/doi.org\/10.1007\/978-3-030-63961-7_9-1.","DOI":"10.1007\/978-3-030-63961-7_9-1"},{"key":"6451_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0021-9150(95)05769-2","volume":"122","author":"F Hirata","year":"1996","unstructured":"Hirata F, Fujita K, Ishikura Y, Hosoda K, Ishikawa T, Nakamura H. Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis. 1996;122:135\u20136. https:\/\/doi.org\/10.1016\/0021-9150(95)05769-2.","journal-title":"Atherosclerosis"},{"key":"6451_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/107424849900400403","volume":"4","author":"D Li","year":"1999","unstructured":"Li D, Saldeen T, Romeo F, Mehta JL. Relative effects of \u03b1- and \u03b3-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Ther. 1999;4:219\u201326. https:\/\/doi.org\/10.1177\/107424849900400403.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"6451_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/BF02536620","volume":"30","author":"AA Qureshi","year":"1995","unstructured":"Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 1995;30:1171\u20137. https:\/\/doi.org\/10.1007\/BF02536620.","journal-title":"Lipids"},{"key":"6451_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clnesp.2021.01.033","volume":"42","author":"HO Santos","year":"2021","unstructured":"Santos HO, Lavie CJ. Weight loss and its influence on high-density lipoprotein cholesterol (HDL-C) concentrations: a noble clinical hesitation. Clin Nutr ESPEN. 2021;42:90\u20132. https:\/\/doi.org\/10.1016\/j.clnesp.2021.01.033.","journal-title":"Clin Nutr ESPEN"},{"key":"6451_CR46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/10408398.2015.1137858","volume":"58","author":"CA Cardoso","year":"2018","unstructured":"Cardoso CA, Oliveira GMM de, Gouveia L de AV, Moreira ASB, Rosa G. The effect of dietary intake of sesame (Sesamumindicum L.) derivatives related to the lipid profile and blood pressure: a systematic review. Crit Rev Food Sci Nutr. 2018;58:116\u201325. https:\/\/doi.org\/10.1080\/10408398.2015.1137858.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"6451_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-10-82","volume":"10","author":"J Wichitsranoi","year":"2011","unstructured":"Wichitsranoi J, Weerapreeyakul N, Boonsiri P, Settasatian C, Settasatian N, Komanasin N, et al. Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans. Nutr J. 2011;10:1\u20137. https:\/\/doi.org\/10.1186\/1475-2891-10-82.","journal-title":"Nutr J"},{"key":"6451_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1248\/bpb.26.1701","volume":"26","author":"D Nakano","year":"2003","unstructured":"Nakano D, Itoh C, Ishii F, Kawanishi H, Takaoka M, Kiso Y, et al. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats. Biol Pharm Bull. 2003;26:1701\u20135. https:\/\/doi.org\/10.1248\/bpb.26.1701.","journal-title":"Biol Pharm Bull"},{"key":"6451_CR49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1248\/bpb.18.1016","volume":"18","author":"Y Matsumura","year":"1995","unstructured":"Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, Oka N, et al. Antihypertensive effect of sesamin. I. protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull. 1995;18:1016\u20139. https:\/\/doi.org\/10.1248\/bpb.18.1016.","journal-title":"Biol Pharm Bull."},{"key":"6451_CR50","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1097\/00004872-200412000-00015","volume":"22","author":"CC Lee","year":"2004","unstructured":"Lee CC, Chen PR, Lin S, Tsai SC, Wang BW, Chen WW, et al. Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect. J Hypertens. 2004;22:2329\u201338. https:\/\/doi.org\/10.1097\/00004872-200412000-00015.","journal-title":"J Hypertens"},{"key":"6451_CR51","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1111\/j.1440-1681.1995.tb02862.x","volume":"22","author":"H Ito","year":"1995","unstructured":"Ito H, Torii M, Suzuki T. Comparative study on free radical injury in the endothelium of SHR and WKY aorta. Clin Exp Pharmacol Physiol. 1995;22:S157\u20139. https:\/\/doi.org\/10.1111\/j.1440-1681.1995.tb02862.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"6451_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/152308603764816541","volume":"5","author":"SR Thomas","year":"2003","unstructured":"Thomas SR, Chen K, Keaney JF. Oxidative stress and endothelial nitric oxide bioactivity. Antioxidants Redox Signal. 2003;5:181\u201394. https:\/\/doi.org\/10.1089\/152308603764816541.","journal-title":"Antioxidants Redox Signal"},{"key":"6451_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jsfa.11265","author":"H Raeisi-Dehkordi","year":"2021","unstructured":"Raeisi-Dehkordi H, Amiri M, Moghtaderi F, Zimorovat A, Rahmanian M, Mozaffari-Khosravi H, et al. Effects of sesame, canola and sesame-canola oils on body weight and composition in adults with type 2 diabetes mellitus: a randomized, triple-blind, cross-over clinical trial. J Sci Food Agric. 2021. https:\/\/doi.org\/10.1002\/jsfa.11265.","journal-title":"J Sci Food Agric"},{"key":"6451_CR54","first-page":"31","volume":"16","author":"M Mosallaieepour-Yazdi","year":"2008","unstructured":"Mosallaieepour-Yazdi M, Eghtesadi S, Kaseb F, Afkhami-Ardakani M, Hoseini F. Effects of sesame oil on blood glucose and lipid profile in type II diabetic patients referring to the Yazd diabetes research center. J Shahid Sadoughi Univ Med Sci Heal Serv. 2008;16:31\u20135.","journal-title":"J Shahid Sadoughi Univ Med Sci Heal Serv"},{"key":"6451_CR55","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","volume":"368","author":"R Estruch","year":"2013","unstructured":"Estruch R, Ros E, Salas-Salvad\u00f3 J, Covas M-I, Corella D, Ar\u00f3s F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279\u201390. https:\/\/doi.org\/10.1056\/NEJMoa1200303.","journal-title":"N Engl J Med"},{"key":"6451_CR56","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacbts.2019.04.001","volume":"4","author":"S Carbone","year":"2019","unstructured":"Carbone S, Billingsley HE, Canada JM, Kadariya D, Medina Chazal H, Rotelli B, et al. Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity and HFpEF: the UFA-preserved pilot study. JACC Basic to Transl Sci. 2019;4:563\u20135. https:\/\/doi.org\/10.1016\/j.jacbts.2019.04.001.","journal-title":"JACC Basic to Transl Sci."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06451-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:11:32Z","timestamp":1657278692000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06451-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6451"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06451-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves human testing, and it was approved by the Institutional Review Board of Isfahan University of Medical Sciences (code: IR.MUI.RESEARCH.REC.1399.548). Written informed consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"551"}}